title: Neutrophil elastase and trastuzumab responsiveness.
authors.forename: Michiko
authors.initials: M
authors.lastname: Harao
authors.forename: Takashi
authors.initials: T
authors.lastname: Sato
authors.forename: Takashi
authors.initials: T
authors.lastname: Fukutomi
authors.forename: Kyoko
authors.initials: K
authors.lastname: Yorozuya
authors.forename: Miyuki
authors.initials: M
authors.lastname: Takasugi
authors.forename: Yukako
authors.initials: Y
authors.lastname: Mohri
authors.forename: Takao
authors.initials: T
authors.lastname: Mizumoto
authors.forename: Satoshi
authors.initials: S
authors.lastname: Takahashi
authors.forename: Jun-ichi
authors.initials: J
authors.lastname: Yamashita
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D005260:Female; D006801:Humans; D019272:Leukocyte Elastase / Q000378:metabolism*; D008954:Models, Biological; D011379:Prognosis; D000068878:Trastuzumab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D019272:Leukocyte Elastase; D000068878:Trastuzumab